[HTML][HTML] Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer

…, V Bautista-Pina, A Maffuz-Aziz, E D'Ippolito… - Scientific reports, 2018 - nature.com
Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive neoplasia lacking
the expression of hormonal receptors and human epidermal growth factor receptor-2. …

[HTML][HTML] MicroRNAs and triple negative breast cancer

E D'Ippolito, MV Iorio - International journal of molecular sciences, 2013 - mdpi.com
Triple Negative Breast Cancer (TNBC) is a very aggressive tumor subtype, which still lacks
specific markers for an effective targeted therapy. Despite the common feature of negativity …

miR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of tumor cells in triple-negative breast cancer

E D'Ippolito, I Plantamura, L Bongiovanni, P Casalini… - Cancer research, 2016 - AACR
Organization of cancer cells into endothelial-like cell-lined structures to support neovascularization
and to fuel solid tumors is a hallmark of progression and poor outcome. In triple-…

COVID‐19 in patients receiving CD20‐depleting immunochemotherapy for B‐cell lymphoma

…, E Georgi, R Woelfel, L Mateyka, E D'Ippolito… - …, 2021 - Wiley Online Library
The clinical and immunological impact of B‐cell depletion in the context of coronavirus disease
2019 (COVID‐19) is unclear. We conducted a prospectively planned analysis of COVID‐…

Long-term persistence and functionality of adoptively transferred antigen-specific T cells with genetically ablated PD-1 expression

…, J Barton, L Cicin-Sain, E D'Ippolito… - Proceedings of the …, 2023 - National Acad Sciences
Engagement of the inhibitory T cell receptor programmed cell death protein 1 (PD-1) associates
with dysfunctional states of pathogen- or tumor-specific T cells. Accordingly, systemic …

Signatures of recent activation identify a circulating T cell compartment containing tumor-specific antigen receptors with high avidity

…, J Barton, S Grassmann, L Pachmayr, E D'Ippolito… - Science …, 2022 - science.org
T cell receptor (TCR) avidity is assumed to be a major determinant of the spatiotemporal
fate and protective capacity of tumor-specific T cells. However, monitoring polyclonal T cell …

[HTML][HTML] CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients

…, CD Spinner, U Protzer, D Hoffmann, E D'Ippolito… - PLoS …, 2022 - journals.plos.org
Background COVID-19 has so far affected more than 250 million individuals worldwide, causing
more than 5 million deaths. Several risk factors for severe disease have been identified, …

T cell engineering for adoptive T cell therapy: safety and receptor avidity

E D'Ippolito, K Schober, M Nauerth… - Cancer immunology …, 2019 - Springer
Since the first bone marrow transplantation, adoptive T cell therapy (ACT) has developed
over the last 80 years to a highly efficient and specific therapy for infections and cancer. …

[PDF][PDF] Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection

…, A Pichlmair, CS Crowell, M Gerhard, E D'Ippolito… - Cell reports, 2022 - cell.com
T cell immunity is crucial for control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection and has been studied widely on a quantitative level. However, the …

[HTML][HTML] Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'

…, CH Mayr, M Strunz, NJ Lang, E D'Ippolito… - Nature …, 2021 - nature.com
The in vivo phenotypic profile of T cells reactive to severe acute respiratory syndrome (SARS)-CoV-2
antigens remains poorly understood. Conventional methods to detect antigen-…